Gabriel Contreras, MD, MPH
Enriched profileProfessor of Clinical Medicine, Katz Family Division of Nephrology and Hypertension · University of Miami Miller School of Medicine
Gabriel Contreras is Professor of Clinical Medicine, Katz Family Division of Nephrology and Hypertension at University of Miami Miller School of Medicine. ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Gabriel Nicolas Contreras Martin, MD, MPH, is Professor of Clinical Medicine, Katz Family Division of Nephrology and Hypertension at University of Miami Miller School of Medicine, Department of Medicine, Katz Family Division of Nephrology and Hypertension. The public record shows 146 publications with 11,650 citations (h-index 49), centered on Nephrology. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2001–2007).
- Top research focus: Nephrology
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Research focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- African American Study of Kidney Disease and Hypertension ABPM Pilot Study
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Industry payments
Updated 31 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20257 payments$23,800openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year20251 payment
- Fresenius USA Marketing, Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.4%Angiotensin receptor blocker (ARB)23.1%Losartan Potassium41%Telmisartan29%Valsartan12%Olmesartan Medoxomil10%Telmisartan-Amlodipine6%Candesartan Cilexetil3%Part D<11 patientsCalcium channel blocker18.3%Amlodipine Besylate87%Nifedipine Er7%Amlodipine-Valsartan6%Part D<11 patientsMetabolism & gastrointestinal
13.4%SGLT2 inhibitor9%Farxiga73%Jardiance27%Part D≥30 patientsVitamin D3 Analog1.6%Calcitriol100%Part D<11 patientsGenitourinary & hormones
2.7%Progestin1.3%Megestrol Acetate100%Part D<11 patientsalpha-Adrenergic Blocker1.3%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 31 Aug 2026
1 NIH research award on record, funded 2001–2007 per NIH RePORTER. The latest:
- African American Study of Kidney Disease and Hypertensi*
University of Miami School of Medicine
FY2007$41,412U01DK048652 - African American Study of Kidney Disease and Hypertensi*
University of Miami School of Medicine
FY2006$164,077U01DK048652 - African American Study of Kidney Disease and Hypertensi*
University of Miami School of Medicine
FY2005$167,076U01DK048652
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Efficacy of Belimumab in Patients with Lupus Nephritis
Clinical Journal of the American Society of Nephrology
2022
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/gabriel-contreras-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
med.miami.edu/faculty/gabriel-nicolas-contreras-md-mph
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - ResearchGate
miami.pure.elsevier.com/en/persons/gabriel-contreras
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →miami.pure.elsevier.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- MPH
Master of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Board Certified
Nephrology, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
Editorial & leadership roles
journal and society appointments- Chair
independent Data Monitoring Committee for participant safety in 2 clinical trials of new lupus nephritis treatments sponsored by Genentech
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jrheum.org ↗ - Site Principal Investigator
African American Study of Kidney Disease and Hypertension (AASK) trial-cohort at University of Miami
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗ - Site Principal Investigator
Systolic Blood Pressure Intervention Trial (SPRINT), NIH-funded
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
Secondary affiliations
appointments beyond the home institution- Jackson Memorial Hospital (Jackson Health System)
affiliated nephrologist
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗ - Miami Veterans Affairs Healthcare System
affiliated hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jrheum.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Sznol, MD
University of Miami Miller School of Medicine
Joshua Hare, MD
University of Miami Miller School of Medicine
Felipe Medeiros, MD
University of Miami Miller School of Medicine
Jeffrey Goldberger, MD
University of Miami Miller School of Medicine